期刊文献+

^18F-FDG PET/CT代谢参数在肺癌中的应用 被引量:25

Application of 18F-FDG PET/CT metabolic parameters in lung cancer
原文传递
导出
摘要 18F-脱氧葡萄糖(FDG) PET/CT显像可同时提供病灶分子水平的代谢信息与精细的解剖形态学信息,在肺癌诊断、疗效评价、预后预测及肿瘤生物靶区定位中有重要价值。18F-FDG PET/CT显像代谢参数主要包括标准摄取值、代谢体积和病灶糖酵解总量等。该文对上述代谢参数在肺癌中的应用加以综述,探讨其应用价值、存在问题及发展趋势。 18F-fluorodeoxyglucose (FDG) PET/CT allows the functional information of PET to be fused with the accurate anatomical information from CT, it demonstrates unique advantages in lung cancer diagnosis, clinical staging, therapeutic evaluation and prognostic stratification. The metabolic parameters from 18F-FDG PET/CT include standardized uptake value, metabolic tumor volume, total lesion glycolysis and so on. This review summarizes the progress, problems and trends about 18F-FDG PET/CT parameters which are currently used in lung cancer.
作者 胡娜 王云华
出处 《中华核医学与分子影像杂志》 CAS 北大核心 2018年第1期59-63,共5页 Chinese Journal of Nuclear Medicine and Molecular Imaging
关键词 肺肿瘤 正电子发射断层显像术 体层摄影术 发射型计算机 脱氧葡萄糖 发展趋势 Lung neoplasms Positron-emission tomography Tomography, emission-computed Deoxyglucose Trends
  • 相关文献

参考文献4

二级参考文献49

  • 1陈虞梅,黄钢,孙晓光,刘建军,施一平,万良荣.PET标准化摄取值在肺癌诊断中的价值及其影响因素的探讨[J].核技术,2007,30(1):65-69. 被引量:10
  • 2于丽娟,锻玉,梁秀艳,王欣.^(18)F-FDG PET/CT显像在肺癌诊断及探查转移灶中的价值[J].中国医学影像技术,2007,23(4):605-607. 被引量:23
  • 3Thie JA. Understanding the standardized uptake value,its methods,and implications for usage[J].The Journal of Nuclear Medicine,2004.1431-1434.
  • 4Yamamoto Y,Nishiyama Y,Monden T. Correlation of FDG-PET findings with histopathology in the assessment of response to induction chemoradiotherapy in no-small cell lung cancer[J].European Journal of Nuclear Medicine and Molecular Imaging,2006.140-147.
  • 5Port JL,Andrade RS,Levin MA. Positron emission tomographic scanning in the diagnosis and staging of non-small cell lung cancer 2 cm in size or less[J].Journal of Thoracic and Cardiovascular Surgery,2005.1611-1615.
  • 6Li M,Liu N,Hu M. Relationship between primary tumor fluorodeoxyglucose uptake and nodal or distant metastases at presentation in T1 stage non-small cell lung cancer[J].Lung Cancer,2009.383-386.
  • 7Azad A,Chionh F,Scott AM. High Impact of 18F-FDG-PET on management and prognostic stratification of newly diagnosed small cell lung cancer[J].Molecular Imaging and Biology,2010.443-451.
  • 8Ak I,Sivrikoz MC,Entok E. Discordant findings in patients with non-small-cell lung cancer:absolutely normal bone scans versus disseminated bone metastases on positron-emission tomography/computed tomography[J].European Journal of Cardio-Thoracic Surgery,2010.792-796.
  • 9Krüger S,Buck AK,Mottaghy FM. Detection of bone metastases in patients with lung cancer:99mTc-MDP planar bone scintigraphy,18F-fluoride PET or 18F-FDG PET/CT[J].European Journal of Nuclear Medicine and Molecular Imaging,2009.1807-1812.
  • 10Song JW,Oh YM,Shim TS. Efficacy comparison between(18)F-FDG PET /CT and bone scintigraphy in detecting bony metastases of non-small-cell lung cancer[J].Lung Cancer,2009.333-338.

共引文献28

同被引文献136

引证文献25

二级引证文献99

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部